ANVISA registration 10337680178ActiveCATECHOLAMINE (NOREPINEPHRINE, EPINEPHRINE, DOPAMINE AND DERIVATIVES)
ANVISA Registration Number: 10337680178GENESE PRODUTOS DIAGNOSTICOS LTDADIASOURCE IMMUNOASSAY SARisk Class II
Device names
- Technical name
- CATECHOLAMINE (NOREPINEPHRINE, EPINEPHRINE, DOPAMINE AND DERIVATIVES)
- Risk class
- Class II
PT: CATECOLAMINA (NORADRENALINA, ADRENALINA, DOPAMINA E DERIVADOS)
Registration details
- Registration Number
- 10337680178
- Process Number
- 25351286792201210
- CNPJ
- 68384155000102
Company information
- Registration Holder
- GENESE PRODUTOS DIAGNOSTICOS LTDA
- Manufacturer
- DIASOURCE IMMUNOASSAY SA
- Manufacturing Country
- Belgium
PT: BÉLGICA
Dates and status
- Publication Date
- Jul 09, 2012
- Validity
- VIGENTE
- Last Updated
- 08/18/2026 19:00:00
About this record
Access comprehensive regulatory information for CATECHOLAMINE (NOREPINEPHRINE, EPINEPHRINE, DOPAMINE AND DERIVATIVES) in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 10337680178 and manufactured by DIASOURCE IMMUNOASSAY SA. The registration is held by GENESE PRODUTOS DIAGNOSTICOS LTDA with validity until currently active (VIGENTE).
This page shows the facts attached to this official registry row. Exact-name links return deterministic registry matches; open-ended comparison and market analysis are handed to AI Search with this record's context, without asserting that similar names represent the same entity.